Maider Medical Industry Equipment (SH:688310) Sou Hu Cai Jing·2025-11-22 20:16Core Viewpoint - The company, Maide Medical, has experienced a decline in stock price and is focusing on its core business development while managing idle funds for better efficiency and returns [1][3]. Group 1: Stock Performance - As of November 21, 2025, Maide Medical's stock closed at 15.2 yuan, down 8.16% from the previous week's 16.55 yuan [1]. - The stock reached a high of 16.87 yuan and a low of 15.05 yuan during the week [1]. - The company's current market capitalization is 2.527 billion yuan, ranking 74th out of 78 in the automation equipment sector and 4810th out of 5167 in the A-share market [1]. Group 2: Business Operations - The company reported a cumulative operating revenue of 225 million yuan for the third quarter of 2025, with an additional 76.452 million yuan in goods issued that have not yet been recognized as revenue [2][4]. - Maide Medical's core products include safety infusion and blood purification intelligent equipment, contributing to revenue growth [2]. - The company has four production lines for contact lenses, each with an annual capacity of 18 million pieces, and is applying for registration of daily disposable soft contact lenses [2][4]. Group 3: Financial Management - The company plans to use up to 35 million yuan of temporarily idle raised funds for cash management, investing in safe, liquid, and principal-protected financial products [3][4]. - This cash management initiative is expected to enhance fund utilization efficiency without affecting the progress of fundraising projects [3][5]. - The decision was approved by the board with unanimous consent and does not require shareholder meeting approval [3][5].